Depression and Anxiety Trial, Recruiting NCT07511088 Sponsor: PLT Health Solutions Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07511088
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 18 and 60 years (both men and women)
  • People who experience episodes of stress or situational anxiety at least once a week
  • People who rate their typical anxiety at 40 or above on a 0–100 scale, where 0 means "not stressed or anxious" and 100 means "extremely stressed or anxious"
  • People who score 20 or higher on the Positive Reactivity section of a specific emotional reactivity questionnaire called the PERS-S
  • People who are able to complete surveys using an online digital platform called Alethios
  • People who are only taking well-established, stable doses of prescription or non-prescription medications that are not used to treat anxiety disorders
  • People who are in generally good health, based on their own reported medical history and the assessment of the lead researcher
  • Women who could become pregnant must agree to use an approved form of birth control during the study (accepted methods include hormonal options such as the pill, implant, injection, ring, or patch; barrier methods such as a condom or diaphragm used with spermicide; or an intrauterine device/IUD)
  • People who agree not to use cannabis for the entire duration of the study
  • People who agree to keep their usual diet and avoid supplements or herbal products associated with calming effects — such as ashwagandha, L-theanine, or St. John's Wort — for the full study period
  • People who are fully informed about the study procedures and agree to take part
  • People who are willing to sign an electronic informed consent form in line with relevant research protection regulations

Who may not be able to join:

  • People who score above 9 on a depression questionnaire called the PHQ-9, or who give any response other than zero to question 9 of that questionnaire (which relates to thoughts of self-harm)
  • People who score above 24 on an anxiety assessment called the Hamilton Anxiety Scale (HAM-A)
  • People with a history of severe psychiatric or medical conditions that could interfere with taking part in the study
  • People who drink more than 14 alcoholic drinks per week
  • People who use cannabis regularly, meaning two or more times per week over the past six weeks
  • People with a history of drug misuse or dependence within the past six months
  • People whose medication for any health condition has changed in the past three months
  • People who are currently taking any prescription medication for anxiety
  • People who have received a diagnosis of a mental health condition within the past three months
  • People with unstable medical conditions (confirm with trial site)
  • People with a known sensitivity or allergic reaction to the study product
  • People who are pregnant, planning to become pregnant, or currently breastfeeding
  • People who are unable to complete the digital/online requirements of the study
  • People who have taken part in another clinical trial within the 30 days before joining this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dawna Salter-Farfan, PhD, RD, PLT Health Solutions

Phone: 620-206-8006

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
PLT Health Solutions
Registry
ClinicalTrials.gov
Start date
29 January 2026
Est. completion
15 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Visual Analog Scale Score; Visual Analog Scale Score; Visual Analog Scale Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov